ClinicalTrials.Veeva

Menu

Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker

C

Corporacion Parc Tauli

Status

Unknown

Conditions

Acute Diverticulitis

Treatments

Other: C-reactive protein

Study type

Observational

Funder types

Other

Identifiers

NCT01825967
2013/532

Details and patient eligibility

About

The management of acute diverticulitis maybe better if we have prognostic markers of evolution.

Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis.

The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.

Full description

A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test.

The investigators will predict evolution of AD with the PCR initial.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute Diverticulitis

Exclusion criteria

  • Other Abdominal Pathologies

Trial design

30 participants in 1 patient group

Acute Diverticulitis
Description:
We measured C-reactive protein in all the patients diagnosed with acute diverticulitis
Treatment:
Other: C-reactive protein

Trial contacts and locations

3

Loading...

Central trial contact

MORA L. LAURA, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems